These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 21775691)
1. Factors associated with antidepressant adherence for Medicaid-enrolled children and adolescents. Fontanella CA; Bridge JA; Marcus SC; Campo JV Ann Pharmacother; 2011 Jul; 45(7-8):898-909. PubMed ID: 21775691 [TBL] [Abstract][Full Text] [Related]
2. Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims. Robinson RL; Long SR; Chang S; Able S; Baser O; Obenchain RL; Swindle RW J Manag Care Pharm; 2006; 12(1):43-54. PubMed ID: 16420107 [TBL] [Abstract][Full Text] [Related]
3. Quality of care for medicaid-covered youth treated with antidepressant therapy. Richardson LP; DiGiuseppe D; Christakis DA; McCauley E; Katon W Arch Gen Psychiatry; 2004 May; 61(5):475-80. PubMed ID: 15123492 [TBL] [Abstract][Full Text] [Related]
4. Association of Antidepressant Medications With Incident Type 2 Diabetes Among Medicaid-Insured Youths. Burcu M; Zito JM; Safer DJ; Magder LS; dosReis S; Shaya FT; Rosenthal GL JAMA Pediatr; 2017 Dec; 171(12):1200-1207. PubMed ID: 29049533 [TBL] [Abstract][Full Text] [Related]
5. Comparative assessment of adherence measures and resource use in SSRI/SNRI-treated patients with depression using second-generation antipsychotics or L-methylfolate as adjunctive therapy. Wade RL; Kindermann SL; Hou Q; Thase ME J Manag Care Pharm; 2014 Jan; 20(1):76-85. PubMed ID: 24372461 [TBL] [Abstract][Full Text] [Related]
6. Antidepressant and antipsychotic use and adherence among Medicaid youths: differences by race. Sleath B; Domino ME; Wiley-Exley E; Martin B; Richards S; Carey T Community Ment Health J; 2010 Jun; 46(3):265-72. PubMed ID: 20091226 [TBL] [Abstract][Full Text] [Related]
7. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders. Sheehan DV; Keene MS; Eaddy M; Krulewicz S; Kraus JE; Carpenter DJ CNS Drugs; 2008; 22(11):963-73. PubMed ID: 18840035 [TBL] [Abstract][Full Text] [Related]
8. Adherence to antidepressant treatment among privately insured patients diagnosed with depression. Akincigil A; Bowblis JR; Levin C; Walkup JT; Jan S; Crystal S Med Care; 2007 Apr; 45(4):363-9. PubMed ID: 17496721 [TBL] [Abstract][Full Text] [Related]
9. Antidepressant monotherapy: A claims database analysis of treatment changes and treatment duration. Milea D; Guelfucci F; Bent-Ennakhil N; Toumi M; Auray JP Clin Ther; 2010 Nov; 32(12):2057-72. PubMed ID: 21118742 [TBL] [Abstract][Full Text] [Related]
10. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Melfi CA; Chawla AJ; Croghan TW; Hanna MP; Kennedy S; Sredl K Arch Gen Psychiatry; 1998 Dec; 55(12):1128-32. PubMed ID: 9862557 [TBL] [Abstract][Full Text] [Related]
11. Trends, characteristics, race, and ethnicity associated with nonadherence to antidepressants among breast cancer survivors with depression. Chang CY; Park H; Hincapie-Castillo JM; Heldermon CD; Diaby V; Yang S; Wilson DL; Lo-Ciganic WH J Manag Care Spec Pharm; 2023 Apr; 29(4):431-445. PubMed ID: 36989452 [No Abstract] [Full Text] [Related]
12. The association of race, comorbid anxiety, and antidepressant adherence among Medicaid enrollees with major depressive disorder. Wu CH; Erickson SR; Piette JD; Balkrishnan R Res Social Adm Pharm; 2012; 8(3):193-205. PubMed ID: 21955808 [TBL] [Abstract][Full Text] [Related]
13. Antidepressant adherence patterns in older patients: use of a clustering method on a prescription database. Braunstein D; Hardy A; Boucherie Q; Frauger E; Blin O; Gentile G; Micallef J Fundam Clin Pharmacol; 2017 Apr; 31(2):226-236. PubMed ID: 27862243 [TBL] [Abstract][Full Text] [Related]
14. Trends in antidepressant prescribing for new episodes of depression and implications for health system quality measures. Pfeiffer PN; Szymanski BR; Valenstein M; McCarthy JF; Zivin K Med Care; 2012 Jan; 50(1):86-90. PubMed ID: 22182925 [TBL] [Abstract][Full Text] [Related]
15. The relationship of guideline-concordant depression treatment and patient adherence to oral diabetes medications. Nau DP; Chao J; Aikens JE Res Social Adm Pharm; 2005 Sep; 1(3):378-88. PubMed ID: 17138485 [TBL] [Abstract][Full Text] [Related]
16. The association of antidepressant medication adherence with employee disability absences. Burton WN; Chen CY; Conti DJ; Schultz AB; Edington DW Am J Manag Care; 2007 Feb; 13(2):105-12. PubMed ID: 17286530 [TBL] [Abstract][Full Text] [Related]
17. Antidepressant Exposure and Risk of Fracture Among Medicaid-Covered Youth. Gracious BL; Fontanella CA; Phillips GS; Bridge JA; Marcus SC; Campo JV J Clin Psychiatry; 2016 Jul; 77(7):e950-6. PubMed ID: 27314252 [TBL] [Abstract][Full Text] [Related]
18. The association between antidepressant dosage titration and medication adherence among patients with depression. Wu CH; Farley JF; Gaynes BN Depress Anxiety; 2012 Jun; 29(6):506-14. PubMed ID: 22553149 [TBL] [Abstract][Full Text] [Related]
19. Effect of regulatory warnings on antidepressant prescribing for children and adolescents. Kurian BT; Ray WA; Arbogast PG; Fuchs DC; Dudley JA; Cooper WO Arch Pediatr Adolesc Med; 2007 Jul; 161(7):690-6. PubMed ID: 17606833 [TBL] [Abstract][Full Text] [Related]
20. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT. Kessler D; Burns A; Tallon D; Lewis G; MacNeill S; Round J; Hollingworth W; Chew-Graham C; Anderson I; Campbell J; Dickens C; Macleod U; Gilbody S; Davies S; Peters TJ; Wiles N Health Technol Assess; 2018 Nov; 22(63):1-136. PubMed ID: 30468145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]